Growth vs. Innovation:
What Drives China’s Healthcare Market?
PROGRAM AGENDA
March 28 - 30, 2017
Shanghai, China
PROGRAM AGENDA & SCHEDULE OF EVENTS
CHIC
DAY 1: TUESDAY, MARCH 28
12:30 pm – 4:30 pm
Pre-Conference & Boot Camp Registration at Shangri-La Pudong Hotel
RIVER WING NANJING ROOM FOYER, 3RD FLOOR
ENTREPRENEUR BOOT CAMP
1:00 pm – 1:05 pm Opening Remarks from Boot Camp Chairs
Gawain Pang, CEO, BioBAY
Karen Wong, Partner, Wilson Sonsini Goodrich & Rosati
RIVER WING NANJING ROOM, 3RD FLOOR
1:05 pm – 2:00 pm
Raising Funds to Kick Start Your Company
Moderator: Yuwen Liu, Founding Partner, BoHe Angel Fund
Kang Ying, CEO, Accuragen
Lingshi Tan, Chairman & CEO, dMed
Fay Xing, Partner, WuXi Healthcare Ventures
2:00 pm – 3:00 pm
Navigating the Clinical Development Path in China and Across the Globe
Moderator: Rachel Zhao, Managing Director, BVCF
Sunny Zhu, Global Clinical Leader, Bayer Healthcare
Zhengyu Yuan, President and CEO, MicuRx
Arthur Zheng, CEO, Pulnovo
Jessica Liu, VP, Head of International Business, TigerMed
3:00 pm – 3:15 pm
Coffee Break
3:15 pm – 4:15 pm
Exploring Creative Cross-Border Collaborations
Moderator: Karen Wong, Partner, Wilson Sonsini Goodrich & Rosati
James Xue, CEO, CANbridge
Lianshan Zhang, President, Global R&D, Hengrui
Jun Bao, SVP & Chief Business Officer, Shenogen
RIVER WING NANJING ROOM FOYER, 3RD FLOOR
RIVER WING NANJING ROOM, 3RD FLOOR
DAY 1: TUESDAY, MARCH 28
ENTREPRENEUR BOOT CAMP
4:15 pm – 5:15 pm
Finding Ways to Make the Exit
Moderator: Jie Zhu, Partner, Wilson Sonsini Goodrich & Rosati
Carl Firth, CEO, Aslan Pharma
Hongke Liu, Managing Director, Consumer and Healthcare, CCBI
Billy Cho, Head of Asia Healthcare, Citi
Felix Fei, Greater China Life Science Sector Co-leader, EY
Hongxin Nie, Managing Partner, SunLand Capital
5:15 pm – 5:30 pm
5:30 pm – 7:00 pm
RIVER WING NANJING ROOM, 3RD FLOOR
Q&A and Closing Remarks
WSGR BayHelix Welcome Cocktail Reception @ Kaefer
“KAEFER BY THE BINJIANG ONE RESTAURANT” LOCATED AT FUCHENG ROAD, SHI BU JIE, BINJIANG DADAO (10 MINUTES WALK FROM HOTEL)
DAY 2: WEDNESDAY, MARCH 29
CHIC
MAIN GENERAL SESSIONS
7:15 am – 8:00 am
Registration at Shangri-La Pudong Hotel
8:00 am – 8:10 am
Opening Remarks
James Li, CEO, JW Therapeutics 8:10 am – 8:40 am
Keynote I: New Policies That Will Promote Innovation
Ruilin Song, Executive President, PhIRDA
8:40 am – 9:10 am Keynote II: Streamlined Regulatory Pathways to Foster Innovation
Department of Drug and Cosmetics Registration
CFDA
9:10 am – 9:40 am Keynote III: What Drives China’s Healthcare Market?
Gaobo Zhou, Partner, China Healthcare Practice, McKinsey & Company
TRACK 1: PHARMACEUTICALS & BIOTECH
Session Chair:
Hongbo Lu, Partner, Lilly Asia Ventures
Billion Dollar Club (Market Cap)
9:40 am – 10:25 am
Company Presentations
Howard Liang, CFO & Chief Strategy Officer, BeiGene
Fenlai Tan, SVP & CMO, Betta Pharma
Frank Zhang, CEO, GenScript
Chasing First-in-Class
10:25 am – 10:40 am
Feature Presentation
Dajun Yang, CEO, Ascentage Pharma
10:40 am – 11:20 am
Panel Discussion
Moderator: Karen Wong, Partner, Wilson Sonsini Goodrich & Rosati
Xianping Lu, CEO & CSO, Chipscreen
Li Chen, CEO, Hua Medicine
Jim Wu, CEO, Ark Biosciences
Jinzi Wu, President and CEO, Ascletis
RIVER WING GRAND BALLROOM FOYER, 3RD FLOOR
RIVER WING GRAND BALLROOM, 3RD FLOOR
DAY 2: WEDNESDAY, MARCH 29
Hot Topic: I.O.
11:20 am – 11:30 am
Feature Presentation
Wenru Song, Co-Founder, Kira Therapeutics
11:30 am – 12:15 pm Panel Discussion
Moderator: Wenru Song, Co-Founder, Kira Therapeutics
Ed Engleman, Professor, Medicine- Immunology, Stanford University / Managing Partner, Vivo Capital
Lei Zheng, Associate Professor, Oncology & Surgery, Johns Hopkins University School of Medicine
Su Yan, Director of Cell Immunotherapy, Eureka Therapeutics
Bing Yuan, SVP, Global Head of Corporate Development, CStone Pharma
12:15 pm – 1:15 pm
Networking Lunch
1:15pm – 2:15 pm
Panel Discussion: Making Cross-Border Deals Moderator: Hongbo Lu, Partner, Lilly Asia Ventures
Ji Li, EVP, Global Head of Business Development, BeiGene
James Xue, CEO, CANbridge
Andrew Chen, Partner, EY
Darren Ji, Venture Partner, Lilly Asia Ventures
Marietta Wu, COO, Zai Lab
TRACK 2: EMERGING INNOVATION COMPANIES
Session Chair: James Li, CEO, JW Therapeutics
Leading the Biologics Wave
2:15 pm – 2:30 pm
Feature Presentation
Michael Yu, CEO & President, Innovent
2:30 pm – 3:15 pm
Panel Discussion
Moderator: Wei Li, Managing Partner, WuXi Healthcare Ventures
Carl Firth, CEO, Aslan Pharma
Dongxu Qiu, SVP, CanSino Biologics
Scott Liu, CEO & President, Henlius Biotech
Xueming Qian, Chairman & CEO, MabSpace Biosciences
Mark Engel, CEO, PhageLux
RIVER WING GRAND BALLROOM, 3RD FLOOR
RIVER WING GRAND BALLROOM, 3RD FLOOR
CHIC
DAY 2: WEDNESDAY, MARCH 29
Emerging Innovation
3:15 pm – 3:30 pm Feature Presentation
Mark Xu, CEO, Xynomic Pharmaceuticals
3:30 pm – 4:10 pm Panel Discussion
Moderator: Dajun Yang, CEO, Ascentage Pharma
Ting Xu, CEO, Alphamab
Frank Jiang, CEO, CStone Pharma
Wen Luo, CEO, Denovo BioPharma
Chengbin Wu, CEO, EpimAb Biotherapeutics
Piers Ingram, CEO, Hummingbird Bioscience
RIVER WING GRAND BALLROOM, 3RD FLOOR
TRACK 3: MEDICAL SERVICES
Session Chair:
Norman Chen, Board Director, DeltaHealth
Opportunities and Challenges Within the China Healthcare Services Sector
4:10 pm – 4:45 pm
Company Presentations
David Hoidal, COO, DeltaHealth
Jacqueline Mei, VP, Strategic Planning Department, Fosun Pharma
Angel Bi, CEO, iBaby
Edward Yiu, CEO, Oriental Speech Therapy
Sijia Lu, CTO, Yikon Genomics
Panel Discussion
Moderators:
4:45 pm – 6:00 pm Rebecca Lin, Partner, Eight Roads Ventures
Nisa Leung, Managing Partner, Qiming Venture Partners
Speakers:
David Hoidal, COO, DeltaHealth
Qiang Zhang, Founder, Dr. Smile Doctor Group
Jacqueline Mei, Strategic Planning Department, Fosun Pharma
Angel Bi, CEO, iBaby
Edward Yiu, CEO, Oriental Speech Therapy
Sijia Lu, CTO, Yikon Genomics
DAY 2: WEDNESDAY, MARCH 29
Closing Remarks
Norman Chen, Board Director, DeltaHealth
6:00 pm – 6:05 pm
6:05 pm – 6:45 pm Cocktail Reception
RIVER WING GRAND BALLROOM, 3RD FLOOR
RIVER WING GRAND BALLROOM FOYER, 3RD FLOOR
6:45 pm – 8:30 pm Gala Dinner & CHIC Award Ceremony
- Announcement of 2017 CHIC Recognition Awards
- Announcement of Deal of the Year Award
- Lucky drawing featuring prizes such iPhone, iPad, Action Cameras, Fitness Bands and more!
RIVER WING GRAND BALLROOM, 3RD FLOOR
CHIC
DAY 3: THURSDAY, MARCH 30
TRACK 4: MEDTECH (DEVICE, INSTRUMENT, DIAGNOSTIC)
Session Chair:
Chen Yu, Managing Partner, Vivo Capital
Global Challenges in MedTech: An Opportunity for China?
9:00 am –9:30 am
MedTech Keynote
Lifei Cheng, VP, Strategy, Business Development & Ventures, Medtronic
9:30 am – 9:45 am
Feature Presentation
9:45 am – 10:45 am
Panel Discussion: China’s Evolving MedTech
Sector: From the Competitor’s Perspective
Chen Yu, Managing Partner, Vivo Capital
Moderator: Michael Chang, Managing Director, Vivo Capital
Alex Gu, VP, President MITG Greater China, Medtronic
John Barr, CEO, Surgical Specialties
Alex Xu, GM, GMT
Victor Chao, GM, Golden Stapler
The Future of Diagnostics and Personalized Medicine in China
10:45 am – 11:00 am
Feature Presentation
Jianbing Fan, CEO, AnchorDx
11:00 am – 12:30 pm Panel Discussion
Qiagen / General Partner, Serica Partners
Moderator: Victor Shi, Founding President, Asia Pacific, Jianbing Fan, CEO, AnchorDx
Richard Ding, CEO, Kehua Bio-Engineering
Philip Huang, Head of Partnering Hub- APAC, Roche Diagnostics
Johny Zhang, CEO, Singlera Genomics
Hongye Sun, CTO and China Head, WuXi NextCODE
RIVER WING GRAND BALLROOM, 3RD FLOOR
TRACK 5: CRO / GLOBAL BIOTECH
Session Chair:
Frank Kung, Managing Partner, Vivo Capital
Renaissance of Innovation Services
9:00 am – 9:30 am
Feature Presentation
Steve Yang, COO, WuXi AppTec
9:30 am – 10:20 am
Panel Discussion
Moderator: Steve Yang, COO, WuXi AppTec
Qian Shi, VP, Oncology, CrownBio
Alex Chen, CEO, Crystal Pharmatech
Racho Jordanov, CEO, JHL Biotech
George Wang, CEO, Mab-Venture
Wen Chen, SVP, Business Development, TigerMed
Global Biotech Company Presentations
10:20 am – 12:30 pm Company Presentations
Moderator:
Josh Berlin, Executive Director & Editor, New Ventures,
BioCentury
Presenting Companies:
Aridis Pharmaceuticals
GattaCo
Lipomedics
Lysomal Therapeutics
Summit Therapeutics
TLC
Unity Biotechnology
RIVER WING GRAND BALLROOM, 3RD FLOOR
DAY 3: THURSDAY, MARCH 30
12:30 pm – 1:30pm Networking Lunch
RIVER WING GRAND BALLROOM, 3RD FLOOR
Panel Discussion: Venture Capital/Private Equity Valuation Gap Between China and the US:
Sustainable or an Arbitrage Opportunity?
1:30 pm – 3:00 pm Moderator: Frank Kung, Managing Partner, Vivo Capital
Rebecca Lin, Partner, Eight Roads Ventures
Dianna Qian, Director, FountainVest
Hongbo Lu, Partner, Lilly Asia Ventures
Jack Yin, Executive Director, SDIC Fund Management
John Zhu, Partner, WuXi Healthcare Ventures
TRACK SIX: HEALTHCARE IT
Session Chair: Cyber Cao, Managing Director, Vivo Capital
3:00 pm – 3:05 pm
Opening Remarks
Cyber Cao, Managing Director, Vivo Capital
3:05 pm – 3:30 pm
Mobile Health: Drivers to Tomorrow
Helen Chen, Managing Director and Partner, L.E.K. Consulting
3:30 pm – 5:00 pm
Company Presentations
Cindy Zhang, China GM, Veeva
Fan Li, Vice President, We Doctor
Peter Ma, CEO, MedBanks
Xingwei Wang, Chairman, Senyint
Tianze Zhang, CEO, Linkdoc
Fengxiang Dai, CFO, HealthWatch
5:00 pm – 5:55 pm
Panel Discussion: How Far to Profitability?
Moderator: Cyber Cao, Managing Director, Vivo Capital
Irene Li, SVP, We Doctor
Xingwei Wang, Chairman, Senyint
Di Liu, CEO, Gmei
Xuguang Ma, CEO, MedBanks
Qirui Chen, CEO, YXJ
5:55 pm – 6:00 pm
Closing Remarks
Hongbo Lu, Partner, Lilly Asia Ventures
RIVER WING GRAND BALLROOM, 3RD FLOOR
Join our WeChat Group!
即刻关注会议微信订阅号!
www.chinahic.com